 Advertisement | ||||||||
 | ||||||||
|
||||||||
 |
 |
 |
 |
 |
 |
 |
||
|
From *the Montreal General Hospital and the Jewish General Hospital, McGill University, Montreal, Que., and University of Alabama School of Public Health, Birmingham, Ala.
Background: Few studies have reported population-based information on the treatment trends and outcomes of patients who have had an acute myocardial infarction (AMI). We therefore examined patterns of care and outcomes for AMI patients in Quebec, Canada, between 1988 and 1995.
Methods: Longitudinal data files of hospital admissions in Quebec (Med-Echo database) and inpatient and outpatient services (Régie de I'Assurance Maladie du Québec database) were used to construct cohorts of all AMI patients in the province between 1988 and 1995. Temporal trends in the use of cardiac procedures after an AMI, discharge prescriptions and mortality rates were examined.
Results: Between 1988 and 1995 the age- and sex-adjusted rates of AMI in the Quebec population declined (148 per 100 000 in 1988 to 137 per 100 000 in 1995). The use of intensive cardiac procedures increased in the same period; the 1-year cumulative incidence rate of catheterization increased from 28% in 1988 to 31% in 1994, that of angioplasty rose from 8% to 15% and that of coronary artery bypass surgery from 6% to 8%. Prescriptions for ASA, ß-blockers, lipid-lowering agents and angiotensin-converting enzyme inhibitors increased, and prescriptions for nitrates and calcium antagonists decreased. These temporal changes were paralleled by a decrease in mortality rates post-AMI. All-cause 1-year cumulative incidence mortality rates decreased from 23% in 1988 to 19% in 1994.
Interpretation: The decrease in AMI-related mortality in Quebec between 1988 and 1995 may be linked to changes in treatment strategies (i.e., increased use of cardiac surgical procedures and medications shown to increase survival).
This article has been cited by other articles:
|
|
 |
|
  S. Setoguchi, R. J. Glynn, J. Avorn, M. A. Mittleman, R. Levin, and W. C. Winkelmayer Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-Year Trend Analysis J. Am. Coll. Cardiol., April 1, 2008; 51(13): 1247 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. E. Boden and D. J. Maron Reducing Post-Myocardial Infarction Mortality in the Elderly: The Power and Promise of Secondary Prevention J. Am. Coll. Cardiol., April 1, 2008; 51(13): 1255 - 1257. [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Waikar, G. C. Curhan, R. Wald, E. P. McCarthy, and G. M. Chertow Declining Mortality in Patients with Acute Renal Failure, 1988 to 2002 J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1143 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Alter, T. A. Stukel, and A. Newman Proliferation of Cardiac Technology in Canada: A Challenge to the Sustainability of Medicare Circulation, January 24, 2006; 113(3): 380 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W Fernandes, S S. Madhavan, M. M Amonkar, D. Bell, S. S Islam, and V. G Scott Outcomes of Inappropriate Prescribing of {beta}-Blockers After an Acute Myocardial Infarction in a Medicaid Population Ann. Pharmacother., September 1, 2005; 39(9): 1416 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Beck, H. Richard, J. V. Tu, and L. Pilote Administrative Data Feedback for Effective Cardiac Treatment: AFFECT, A Cluster Randomized Trial JAMA, July 20, 2005; 294(3): 309 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hudson, H. Richard, and L. Pilote Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study BMJ, June 11, 2005; 330(7504): 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pilote, M. Abrahamowicz, E. Rodrigues, M. J. Eisenberg, and E. Rahme Mortality Rates in Elderly Patients Who Take Different Angiotensin-Converting Enzyme Inhibitors after Acute Myocardial Infarction: A Class Effect? Ann Intern Med, July 20, 2004; 141(2): 102 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Essebag, T. Hadjis, R. W. Platt, and L. Pilote Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction J. Am. Coll. Cardiol., January 15, 2003; 41(2): 249 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pilote, C. Beck, H. Richard, and M. J. Eisenberg The effects of cost-sharing on essential drug prescriptions, utilization of medical care and outcomes after acute myocardial infarction in elderly patients Can. Med. Assoc. J., August 1, 2002; 167(3): 246 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Rahme, L. Pilote, and J. LeLorier Association Between Naproxen Use and Protection Against Acute Myocardial Infarction Arch Intern Med, May 27, 2002; 162(10): 1111 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Feldman, C. Thivierge, L. Guerard, V. Dery, C. Kapetanakis, G. Lavoie, and E. J. Beck Changing trends in mortality and admissions to hospital for elderly patients with congestive heart failure in Montreal Can. Med. Assoc. J., October 1, 2001; 165(8): 1033 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kollek Treating acute myocardial infarction Can. Med. Assoc. J., February 1, 2001; 164(3): 323 - 323. [Full Text] [PDF]
|
|
|
|
|
|
W. D. Panton Treating acute myocardial infarction Can. Med. Assoc. J., February 1, 2001; 164(3): 323 - 324. [Full Text]
|
|
|
|
|
|
A. Dodek Acute myocardial infarction in Canada: improvement with time Can. Med. Assoc. J., July 1, 2000; 163(1): 41 - 42. [Full Text] [PDF]
|
|
| HOME | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | HELP | SEARCH |
|
|||||
|
Copyright 1995-2000, Canadian Medical Association. All rights reserved. ISSN 1488-2329
(e) 0820-3946 (p)
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association. |
|||||
